Works by Witzig, Thomas


Results: 234
    1
    2

    Heavy chain disease.

    Published in:
    2002
    By:
    • Witzig, Thomas;
    • Roedler, Dietlind;
    • Witzig, Thomas E;
    • Wahner-Roedler, Dietlind L
    Publication type:
    journal article
    3

    Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01322-9
    By:
    • Atallah-Yunes, Suheil Albert;
    • Rees, Matthew J.;
    • Mwangi, Raphael;
    • Kuchler, Robyn L.;
    • Alnughmush, Ahmed;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Villasboas Bisneto, Jose C.;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    4

    Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 394, doi. 10.1002/jha2.394
    By:
    • Nastoupil, Loretta J.;
    • Kuruvilla, John;
    • Chavez, Julio C.;
    • Bijou, Fontanet;
    • Witzig, Thomas E.;
    • Santoro, Armando;
    • Flinn, Ian W.;
    • Boccomini, Carola;
    • Kenkre, Vaishalee P.;
    • Corradini, Paolo;
    • Isufi, Iris;
    • Andorsky, David J.;
    • Klein, Leonard M.;
    • Greenwald, Daniel R.;
    • Sangha, Randeep;
    • Shen, Frank;
    • Hagner, Patrick;
    • Li, Yan;
    • Dobmeyer, Juergen;
    • Gong, Nian
    Publication type:
    Article
    5
    6
    7
    8
    9

    A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325
    By:
    • Tolcher, Anthony;
    • Flaherty, Keith;
    • Shapiro, Geoffrey I.;
    • Berlin, Jordan;
    • Witzig, Thomas;
    • Habermann, Thomas;
    • Bullock, Andrea;
    • Rock, Edwin;
    • Elekes, Agnes;
    • Lin, Chester;
    • Kostic, Dusan;
    • Ohi, Naoto;
    • Rasco, Drew;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Smith, Lon;
    • Cote, Gregory M.
    Publication type:
    Article
    10

    Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse post autologous stem cell transplant.

    Published in:
    European Journal of Haematology, 2014, v. 92, n. 2, p. 1, doi. 10.1111/ejh.12282
    By:
    • Warsame, Rahma;
    • Soo Mee Bang;
    • Kumar, Shaji K.;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Buadi, Francis;
    • Dingli, David;
    • Hayman, Suzanne R.;
    • Prashant, Kapoor;
    • Kyle, Robert A.;
    • Leung, Nelson;
    • Lust, John A.;
    • Russell, Stephen J.;
    • Witzig, Thomas E.;
    • Zeldenrust, Steven R.;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela
    Publication type:
    Article
    11

    Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.

    Published in:
    European Journal of Haematology, 2006, v. 77, n. 5, p. 387, doi. 10.1111/j.1600-0609.2006.00725.x
    By:
    • Visco, Carlo;
    • Nadali, Gianpaolo;
    • Vassilakopoulos, Theodoros P.;
    • Bonfante, Valeria;
    • Viviani, Simonetta;
    • Gianni, Alessandro M.;
    • Federico, Massimo;
    • Luminari, Stefano;
    • Peethambaram, Prema;
    • Witzig, Thomas E.;
    • Pangalis, Gerassimos;
    • Cabanillas, Fernando;
    • Medeiros, L. Jeffrey;
    • Sarris, Andreas H.;
    • Pizzolo, Giovanni
    Publication type:
    Article
    12

    Targeted therapy in lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2010, v. 3, p. 45, doi. 10.1186/1756-8722-3-45
    By:
    • Johnston, Patrick B.;
    • RuiRong Yuan;
    • Cavalli, Franco;
    • Witzig, Thomas E.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 980, doi. 10.1002/ajh.27663
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Perera, Nirosha D.;
    • Sarosiek, Shayna;
    • Gustine, Joshua;
    • Ramirez‐Gamero, Andres;
    • Varettoni, Marzia;
    • Tedeschi, Alessandra;
    • Cavalloni, Chiara;
    • Frustaci, Anna Maria;
    • Pederson, Levi D.;
    • Zanwar, Saurabh S.;
    • Kapoor, Prashant;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Geyer, Susan M.;
    • Treon, Steven P.;
    • Castillo, Jorge J.
    Publication type:
    Article
    20

    Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 218, doi. 10.1002/ajh.27533
    By:
    • Witzig, Thomas E.;
    • Taylor, William R.;
    • Mahoney, Douglas W.;
    • Bamlet, William R.;
    • Foote, Patrick H.;
    • Burger, Kelli N.;
    • Doering, Karen A.;
    • Devens, Mary E.;
    • Arndt, Jacquelyn R.;
    • O'Connell, Maria C.;
    • Berger, Calise K.;
    • Novak, Anne J.;
    • Cerhan, James R.;
    • Hennek, Jacquelyn;
    • Katerov, Slava;
    • Allawi, Hatim T.;
    • Jevremovic, Dragan;
    • Dao, Linda N.;
    • Graham, Rondell P.;
    • Kisiel, John B.
    Publication type:
    Article
    21
    22

    The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 408, doi. 10.1002/ajh.27202
    By:
    • Cerhan, James R.;
    • Maurer, Matthew J.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Habermann, Thomas M.;
    • Jaye, David L.;
    • Burack, W. Richard;
    • McDonnell, Timothy J.;
    • Vega, Francisco;
    • Chapman, Jennifer R.;
    • Syrbu, Sergei;
    • Vij, Kiran R.;
    • Inghirami, Giorgio;
    • Leonard, John P.;
    • Bernal‐Mizrachi, Leon;
    • Farooq, Umar;
    • Witzig, Thomas E.;
    • Weiner, George J.;
    • Wang, Yucai;
    • Alderuccio, Juan P.
    Publication type:
    Article
    23

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    24

    Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
    By:
    • Seegobin, Karan;
    • Li, Zhuo;
    • Alhaj Moustafa, Muhamad;
    • Majeed, Umair;
    • Wang, Jing;
    • Jiang, Liuyan;
    • Kuhlman, Justin;
    • Menke, David;
    • Li, Ke;
    • Kharfan‐Dabaja, Mohamed A.;
    • Ayala, Ernesto;
    • Iqbal, Madiha;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Johnston, Patrick;
    • Thompson, Carrie;
    • Ansell, Stephen;
    • Tun, Han W.
    Publication type:
    Article
    25

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    26

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    27

    Testicular FDG‐PET/CT uptake threshold in aggressive lymphomas.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 3, p. E81, doi. 10.1002/ajh.26073
    By:
    • Higgins, Alexandra;
    • Kim, Hidong;
    • Harper, Laura;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Johnston, Patrick;
    • Witzig, Thomas E.;
    • Allmer, Cristine;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Young, Jason R.;
    • Thanarajasingam, Gita
    Publication type:
    Article
    28

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    29
    30

    Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 6, p. E153, doi. 10.1002/ajh.25451
    By:
    • Wang, Yucai;
    • Habermann, Thomas M.;
    • Wang, Sophia S.;
    • Maurer, Matthew J.;
    • Sarangi, Vivekananda;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Cozen, Wendy;
    • Rothman, Nathaniel;
    • Asmann, Yan;
    • Slager, Susan L.;
    • Cerhan, James R.
    Publication type:
    Article
    31

    Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
    By:
    • Castellino, Alessia;
    • Pulido, Jose S.;
    • Johnston, Patrick B.;
    • Ristow, Kay M.;
    • Nora Bennani, N.;
    • Inwards, David J.;
    • Macon, William R.;
    • Micallef, Ivana N. M.;
    • King, Rebecca L.;
    • Salomao, Diva R.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    32

    The association of physical activity before and after lymphoma diagnosis with survival outcomes.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 12, p. 1543, doi. 10.1002/ajh.25288
    By:
    • Pophali, Priyanka A.;
    • Ip, Andrew;
    • Larson, Melissa C.;
    • Rosenthal, Allison C.;
    • Maurer, Matthew J.;
    • Flowers, Christopher R.;
    • Link, Brian K.;
    • Farooq, Umar;
    • Feldman, Andrew L.;
    • Allmer, Cristine;
    • Slager, Susan L.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Cohen, Jonathon B.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    33

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    34

    <italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
    By:
    • Abeykoon, Jithma P.;
    • Paludo, Jonas;
    • King, Rebecca L.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • LaPlant, Betsy R.;
    • Halvorson, Alese E.;
    • Gonsalves, Wilson I.;
    • Dingli, David;
    • Fang, Hong;
    • Rajkumar, S. Vincent;
    • Lacy, Martha Q.;
    • He, Rong;
    • Kourelis, Taxiarchis;
    • Reeder, Craig B.;
    • Novak, Anne J.;
    • McPhail, Ellen D.;
    • Viswanatha, David S.;
    • Witzig, Thomas E.;
    • Go, Ronald S.
    Publication type:
    Article
    35
    36

    Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
    By:
    • Witzig, Thomas E.;
    • Johnston, Patrick B.;
    • LaPlant, Betsy R.;
    • Kurtin, Paul J.;
    • Pederson, Levi D.;
    • Moore Jr, Dennis F.;
    • Nabbout, Nassim H.;
    • Nikcevich, Daniel A.;
    • Rowland, Kendrith M.;
    • Grothey, Axel
    Publication type:
    Article
    37
    38

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    39
    40

    Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 2, p. 179, doi. 10.1002/ajh.24223
    By:
    • Maurer, Matthew J.;
    • Jais, Jean-Philippe;
    • Ghesquières, Hervé;
    • Witzig, Thomas E.;
    • Hong, Fangxin;
    • Haioun, Corinne;
    • Thompson, Carrie A.;
    • Thieblemont, Catherine;
    • Micallef, Ivana N.;
    • Porrata, Luis F.;
    • Ribrag, Vincent;
    • Nowakowski, Gregorz S.;
    • Casasnovas, Olivier;
    • Bologna, Serge;
    • Morschhauser, Franck;
    • Morrison, Vicki A.;
    • Peterson, Bruce A.;
    • Macon, William R.;
    • Copie-Bergman, Christiane;
    • Feldman, Andrew L.
    Publication type:
    Article
    41
    42

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    43
    44
    45

    Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
    By:
    • Zent, Clive S.;
    • Taylor, Ronald P.;
    • Lindorfer, Margaret A.;
    • Beum, Paul V.;
    • LaPlant, Betsy;
    • Wu, Wenting;
    • Call, Timothy G.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Frederick, Lori A.;
    • Link, Brian K.;
    • Blackwell, Sue E.;
    • Veeramani, Suresh;
    • Baig, Nisar A.;
    • Viswanatha, David S.;
    • Weiner, George J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    46
    47
    48
    49

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    50

    Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 5, p. 375, doi. 10.1002/ajh.23413
    By:
    • Kourelis, Taxiarchis V.;
    • Gertz, Morie;
    • Zent, Clive;
    • Lacy, Martha;
    • Kyle, Robert;
    • Kapoor, Prashant;
    • Zeldenrust, Steven;
    • Buadi, Francis;
    • Witzig, Thomas;
    • Hayman, Suzanne;
    • Lust, John;
    • Russell, Stephen;
    • Lin, Yi;
    • Rajkumar, Vincent S.;
    • Kumar, Shaji;
    • Leung, Nelson;
    • Dingli, David;
    • Dispenzieri, Angela
    Publication type:
    Article